Bessemer Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Sell
3,383
-354
-9% -$150K ﹤0.01% 946
2026
Q1
$1.77M Buy
3,737
+485
+15% +$244K ﹤0.01% 832
2025
Q4
$1.52M Sell
3,252
-112
-3% -$52K ﹤0.01% 866
2025
Q3
$1.43M Buy
3,364
+536
+19% +$208K ﹤0.01% 567
2025
Q2
$1.08M Buy
2,828
+42
+2% +$15.1K ﹤0.01% 622
2025
Q1
$962K Sell
2,786
-5,112
-65% -$1.64M ﹤0.01% 715
2024
Q4
$2.37M Sell
7,898
-173
-2% -$60.5K ﹤0.01% 612
2024
Q3
$3.28M Buy
8,071
+820
+11% +$300K 0.01% 548
2024
Q2
$2.33M Sell
7,251
-378
-5% -$123K ﹤0.01% 483
2024
Q1
$2.54M Buy
7,629
+2,584
+51% +$790K ﹤0.01% 486
2023
Q4
$1.37M Sell
5,045
-1,205
-19% -$298K ﹤0.01% 576
2023
Q3
$1.54M Buy
6,250
+323
+5% +$88.4K ﹤0.01% 524
2023
Q2
$1.8M Buy
5,927
+266
+5% +$74K ﹤0.01% 501
2023
Q1
$1.49M Sell
5,661
-413
-7% -$105K ﹤0.01% 509
2022
Q4
$1.46M Sell
6,074
-116
-2% -$26K ﹤0.01% 505
2022
Q3
$1.14M Buy
6,190
+209
+3% +$41.6K ﹤0.01% 551
2022
Q2
$1M Sell
5,981
-494
-8% -$106K ﹤0.01% 571
2022
Q1
$1.62M Buy
6,475
+1,638
+34% +$411K ﹤0.01% 393
2021
Q4
$1.24M Buy
4,837
+1,662
+52% +$407K ﹤0.01% 423
2021
Q3
$771K Buy
3,175
+45
+1% +$11K ﹤0.01% 470
2021
Q2
$647K Buy
3,130
+108
+4% +$22K ﹤0.01% 509
2021
Q1
$569K Buy
3,022
+100
+3% +$17.6K ﹤0.01% 513
2020
Q4
$480K Buy
2,922
+708
+32% +$104K ﹤0.01% 539
2020
Q3
$276K Sell
2,214
-6,511
-75% -$806K ﹤0.01% 654
2020
Q2
$847K Buy
8,725
+8,362
+2,304% +$869K ﹤0.01% 849
2020
Q1
$33K Buy
363
+133
+58% +$17.2K ﹤0.01% 1282
2019
Q4
$34K Sell
230
-692
-75% -$92.9K ﹤0.01% 1316
2019
Q3
$111K Buy
922
+377
+69% +$48.7K ﹤0.01% 1158
2019
Q2
$73K Sell
545
-54
-9% -$6.83K ﹤0.01% 1251
2019
Q1
$78K Sell
599
-429
-42% -$57.6K ﹤0.01% 1191
2018
Q4
$128K Sell
1,028
-6
-0.6% -$805 ﹤0.01% 1089
2018
Q3
$144K Buy
1,034
+37
+4% +$4.61K ﹤0.01% 1049
2018
Q2
$102K Buy
997
+21
+2% +$2.13K ﹤0.01% 1109
2018
Q1
$95K Hold
976
﹤0.01% 1140
2017
Q4
$86K Sell
976
-24
-2% -$1.93K ﹤0.01% 1166
2017
Q3
$80K Buy
1,000
+50
+5% +$4.02K ﹤0.01% 1224
2017
Q2
$83K Hold
950
﹤0.01% 1214
2017
Q1
$85K Sell
950
-60
-6% -$5K ﹤0.01% 1222
2016
Q4
$74K Buy
1,010
+60
+6% +$4.49K ﹤0.01% 1271
2016
Q3
$72K Sell
950
-2,705
-74% -$207K ﹤0.01% 1159
2016
Q2
$281K Hold
3,655
﹤0.01% 621
2016
Q1
$285K Sell
3,655
-62
-2% -$4.33K ﹤0.01% 629
2015
Q4
$251K Sell
3,717
-439
-11% -$30.6K ﹤0.01% 714
2015
Q3
$322K Buy
4,156
+2,876
+225% +$255K ﹤0.01% 708
2015
Q2
$116K Sell
1,280
-2,705
-68% -$217K ﹤0.01% 825
2015
Q1
$300K Buy
3,985
+310
+8% +$22.3K ﹤0.01% 677
2014
Q4
$270K Buy
3,675
+545
+17% +$38.3K ﹤0.01% 667
2014
Q3
$221K Buy
3,130
+910
+41% +$60.1K ﹤0.01% 675
2014
Q2
$125K Buy
2,220
+1,270
+134% +$67K ﹤0.01% 738
2014
Q1
$50K Hold
950
﹤0.01% 864
2013
Q4
$45K Hold
950
﹤0.01% 881
2013
Q3
$41K Sell
950
-600
-39% -$23.4K ﹤0.01% 850
2013
Q2
$56K Buy
+1,550
New +$60K ﹤0.01% 749

Other funds holding HCA

Bessemer Group's HCA Position: Q2 2026 in Review

Bessemer Group reduced its HCA Healthcare (HCA) stake by 9.5% in Q2 2026, selling an estimated $150K and leaving 3,383 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #946.

Bessemer Group first reported a position in HCA in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.28M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Bessemer Group held 3,383 shares of HCA Healthcare worth $1.32M as of Q2 2026.
  • Bessemer Group sold 354 HCA Healthcare shares in Q2 2026, an estimated $150K.
  • HCA Healthcare made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #946 holding.
  • Bessemer Group first reported a position in HCA Healthcare in Q2 2013 and has held it in 53 quarters since.
  • Bessemer Group's HCA Healthcare position peaked at $3.28M in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.